228 related articles for article (PubMed ID: 31646789)
1. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
Zhuang H; Cao G; Kou C; Li D
J BUON; 2019; 24(4):1441-1448. PubMed ID: 31646789
[TBL] [Abstract][Full Text] [Related]
2. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis.
Huang Y; Xiang B; Liu Y; Wang Y; Kan H
Cancer Lett; 2018 Nov; 437():56-66. PubMed ID: 30165194
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA
Zhou N; Li S; Wu D; Zhang F; Tang F; Li Y
DNA Cell Biol; 2021 Oct; 40(10):1278-1289. PubMed ID: 34558987
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma.
Sheng N; Li Y; Qian R; Li Y
Biomed Pharmacother; 2018 Feb; 98():577-584. PubMed ID: 29288973
[TBL] [Abstract][Full Text] [Related]
6.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
7. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53.
Luo X; Zhou N; Wang L; Zeng Q; Tang H
Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
[TBL] [Abstract][Full Text] [Related]
11. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
Wei C; Wang H; Xu F; Liu Z; Jiang R
Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
Ma CX; Gao WC; Tian L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy.
Hong F; Gao Y; Li Y; Zheng L; Xu F; Li X
World J Surg Oncol; 2020 May; 18(1):113. PubMed ID: 32473641
[TBL] [Abstract][Full Text] [Related]
17. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation.
Su Y; Xie R; Xu Q
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102025. PubMed ID: 36170961
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of IncRNA TPT1-AS1 Suppresses Hepatocellular Carcinoma Cell Proliferation by Downregulating CDK2.
Wei W; Huang X; Shen X; Lian J; Chen Y; Wang W; Huang J; Zhang B
Crit Rev Eukaryot Gene Expr; 2022; 32(1):1-9. PubMed ID: 35377976
[TBL] [Abstract][Full Text] [Related]
19. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
20. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
Zhao LP; Li RH; Han DM; Zhang XQ; Nian GX; Wu MX; Feng Y; Zhang L; Sun ZG
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5353-5360. PubMed ID: 29243775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]